Skip to content

A comparison between two regimes for Labour induction in Intrauterine fetal death

A RANDOMIZED DOUBLE-BLIND STUDY TO COMPARE EFFICACY OF MIFEPRISTONE AND MISOPROSTOL VERSUS MISOPROSTOL ALONE FOR INDUCTION OF LABOUR IN INTRAUTERINE FOETAL DEATH.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2014/03/004489
Enrollment
100
Registered
2014-03-21
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- WOMEN diagnosed with intrauterine foetal death after 20 weeks of pregnancy.

Interventions

Intervention1: MIFEPRISTONE AND MISOPROSTOL: 200mg mifepristone tablet orally followed after 36-48 hrs by misoprostol,50-100µg vaginally at the interval of 6hrs for 4doses. Control Intervention1: P

Sponsors

NRS MEDICAL COLLEGE KOLKATA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Women with period of gestation >20 weeks presenting with dead fetus as confirmed by ultrasonography without clinical evidence of active labour, bleeding per vagina, or ruptured membranes were included.

Exclusion criteria

Exclusion criteria: Women who had known allergy to mifepristone and misoprostol or had contraindications for the use of two drugs were excluded. b. Women with known previous transmural uterine incision (caeserian section, myomectomy), with grand multiparity ( > 4 ,with Haemoglobin level below 8 gm/dl or with any medical problem as renal, liver, cardiovascular diseases or coagulopathy were also excluded. c. Women who had low lying placenta as demonstrated by ultrasonography and who showed evidence of infection, who were in active labour or had bleeding or leaking per vagina were not included.

Design outcomes

Primary

MeasureTime frame
.Rate of successful delivery without additional intervention. 2. Induction to delivery intervalTimepoint: 24 hours

Secondary

MeasureTime frame
1.additional interventions needed 2.side effects and complications. Timepoint: 1.24 hours 2.6 weeks

Countries

India

Contacts

Public ContactDrPICKLU CHAUDHURI

NRS MEDICAL COLLEGE,KOLKATA

picklu.chaudhuri@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026